286 related articles for article (PubMed ID: 22605924)
1. Transcriptome analysis using next generation sequencing reveals molecular signatures of diabetic retinopathy and efficacy of candidate drugs.
Kandpal RP; Rajasimha HK; Brooks MJ; Nellissery J; Wan J; Qian J; Kern TS; Swaroop A
Mol Vis; 2012; 18():1123-46. PubMed ID: 22605924
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomics analysis of pericytes from retinas of diabetic animals reveals novel genes and molecular pathways relevant to blood-retinal barrier alterations in diabetic retinopathy.
Rangasamy S; Monickaraj F; Legendre C; Cabrera AP; Llaci L; Bilagody C; McGuire P; Das A
Exp Eye Res; 2020 Jun; 195():108043. PubMed ID: 32376470
[TBL] [Abstract][Full Text] [Related]
3. Single-cell transcriptome analysis of the Akimba mouse retina reveals cell-type-specific insights into the pathobiology of diabetic retinopathy.
Van Hove I; De Groef L; Boeckx B; Modave E; Hu TT; Beets K; Etienne I; Van Bergen T; Lambrechts D; Moons L; Feyen JHM; Porcu M
Diabetologia; 2020 Oct; 63(10):2235-2248. PubMed ID: 32734440
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE).
Zong H; Ward M; Madden A; Yong PH; Limb GA; Curtis TM; Stitt AW
Diabetologia; 2010 Dec; 53(12):2656-66. PubMed ID: 20835858
[TBL] [Abstract][Full Text] [Related]
5. Tiam1-Rac1 Axis Promotes Activation of p38 MAP Kinase in the Development of Diabetic Retinopathy: Evidence for a Requisite Role for Protein Palmitoylation.
Veluthakal R; Kumar B; Mohammad G; Kowluru A; Kowluru RA
Cell Physiol Biochem; 2015; 36(1):208-20. PubMed ID: 25967961
[TBL] [Abstract][Full Text] [Related]
6. RNA sequencing reveals BMP4 as a basis for the dual-target treatment of diabetic retinopathy.
Dong L; Zhang Z; Liu X; Wang Q; Hong Y; Li X; Liu J
J Mol Med (Berl); 2021 Feb; 99(2):225-240. PubMed ID: 33188599
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia.
Li G; Tang J; Du Y; Lee CA; Kern TS
Mol Vis; 2011; 17():3156-65. PubMed ID: 22171162
[TBL] [Abstract][Full Text] [Related]
8. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HOTTIP improves diabetic retinopathy by regulating the p38-MAPK pathway.
Sun Y; Liu YX
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2941-2948. PubMed ID: 29863235
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane inhibits advanced glycation end product-induced pericyte damage by reducing expression of receptor for advanced glycation end products.
Maeda S; Matsui T; Ojima A; Takeuchi M; Yamagishi S
Nutr Res; 2014 Sep; 34(9):807-13. PubMed ID: 25241332
[TBL] [Abstract][Full Text] [Related]
12. Next-generation sequencing facilitates quantitative analysis of wild-type and Nrl(-/-) retinal transcriptomes.
Brooks MJ; Rajasimha HK; Roger JE; Swaroop A
Mol Vis; 2011; 17():3034-54. PubMed ID: 22162623
[TBL] [Abstract][Full Text] [Related]
13. Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice.
McVicar CM; Ward M; Colhoun LM; Guduric-Fuchs J; Bierhaus A; Fleming T; Schlotterer A; Kolibabka M; Hammes HP; Chen M; Stitt AW
Diabetologia; 2015 May; 58(5):1129-37. PubMed ID: 25687235
[TBL] [Abstract][Full Text] [Related]
14. A cross talk between class A scavenger receptor and receptor for advanced glycation end-products contributes to diabetic retinopathy.
Ma K; Xu Y; Wang C; Li N; Li K; Zhang Y; Li X; Yang Q; Zhang H; Zhu X; Bai H; Ben J; Ding Q; Li K; Jiang Q; Xu Y; Chen Q
Am J Physiol Endocrinol Metab; 2014 Dec; 307(12):E1153-65. PubMed ID: 25352436
[TBL] [Abstract][Full Text] [Related]
15. Diabetes regulates small molecular weight G-protein, H-Ras, in the microvasculature of the retina: implication in the development of retinopathy.
Kanwar M; Kowluru RA
Microvasc Res; 2008 Nov; 76(3):189-93. PubMed ID: 18514235
[TBL] [Abstract][Full Text] [Related]
16. The role of high mobility group box 1 (HMGB-1) in the diabetic retinopathy inflammation and apoptosis.
Yu Y; Yang L; Lv J; Huang X; Yi J; Pei C; Shao Y
Int J Clin Exp Pathol; 2015; 8(6):6807-13. PubMed ID: 26261566
[TBL] [Abstract][Full Text] [Related]
17. RNA sequencing reveals retinal transcriptome changes in STZ-induced diabetic rats.
Liu YJ; Lian ZY; Liu G; Zhou HY; Yang HJ
Mol Med Rep; 2016 Mar; 13(3):2101-9. PubMed ID: 26781437
[TBL] [Abstract][Full Text] [Related]
18. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM
Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026
[TBL] [Abstract][Full Text] [Related]
19. Up-Regulation Thioredoxin Inhibits Advanced Glycation End Products-Induced Neurodegeneration.
Ren X; Wang NN; Qi H; Qiu YY; Zhang CH; Brown E; Kong H; Kong L
Cell Physiol Biochem; 2018; 50(5):1673-1686. PubMed ID: 30384364
[TBL] [Abstract][Full Text] [Related]
20. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
